How should allergic disease be treated in a patient with hypertension?

Treatment of Allergic Disease in Hypertensive Patients

In hypertensive patients with allergies, second-generation oral antihistamines (cetirizine, loratadine, fexofenadine) or intranasal corticosteroids are the preferred first-line treatments, as they effectively control allergic symptoms without adversely affecting blood pressure. 1

Medication Selection Algorithm

First-Line Allergy Treatments (Safe in Hypertension)

Second-generation oral antihistamines are the optimal initial choice for allergic rhinitis in hypertensive patients:

• Cetirizine 10 mg daily, loratadine 10 mg daily, fexofenadine 180 mg daily, or levocetirizine 5 mg daily 1
• These agents effectively reduce rhinorrhea, sneezing, itching, and allergic conjunctivitis symptoms without elevating blood pressure 1
• If inadequate response within 24-48 hours, increase dosing up to 4 times the standard dose (e.g., cetirizine 40 mg daily) 1
• Preferred over first-generation antihistamines due to reduced sedation and anticholinergic effects 1

Intranasal corticosteroids are particularly effective for moderate-to-severe allergic rhinitis:

• Most effective medication class for controlling all four major symptoms: sneezing, itching, rhinorrhea, and nasal congestion 1
• No clinically significant systemic effects on blood pressure at recommended doses 1
• Can be initiated without prior antihistamine trial in more severe cases 1
• Direct spray away from nasal septum to minimize local irritation and bleeding 1

Medications Requiring Caution

Oral decongestants (pseudoephedrine, phenylephrine) should be used cautiously:

• Elevation of blood pressure is very rarely noted in normotensive patients and only occasionally in patients with controlled hypertension 1
• However, hypertensive patients should be monitored due to interindividual variation in response 1
• Pseudoephedrine is probably safer than phenylpropanolamine, which should be avoided 2
• Nasal phenylephrine is probably the safest adrenergic agent if decongestant use is necessary 2

Topical decongestants have limited role:

• Appropriate only for short-term use (≤3 days) to avoid rhinitis medicamentosa 1
• Risk of rebound congestion develops in some patients within 3 days, though others tolerate 4-6 weeks 1
• Not recommended for routine management in hypertensive patients 1

Adjunctive Treatments

Leukotriene receptor antagonists (LTRAs) are safe alternatives:

• Efficacy comparable to antihistamines for allergic rhinitis 1
• Concomitant use with antihistamines may provide additive benefit, though less effective than intranasal corticosteroids 1
• No adverse effects on blood pressure 1

Short-course oral corticosteroids for severe exacerbations:

• Prednisone 0.5-1 mg/kg daily (typically 40-60 mg) for 5-7 days 1
• Should only be used after intranasal corticosteroids have been considered 1
• No significant blood pressure effects with short courses 1

Special Considerations for Allergen Immunotherapy

If considering allergen immunotherapy in hypertensive patients on specific medications:

Beta-blockers and immunotherapy:

• Concomitant use of beta-blockers with inhalant allergen immunotherapy increases risk of severe anaphylactic reactions 1
• For uncomplicated hypertension, replace beta-blocker with equally efficacious alternative antihypertensive before initiating immunotherapy 1
• If beta-blocker cannot be replaced (e.g., post-myocardial infarction prophylaxis), withholding immunotherapy is generally most prudent 1
• Exception: For venom immunotherapy in life-threatening insect allergy, concomitant administration with beta-blocker is warranted when no alternative exists 1
• Glucagon may be efficacious for treatment of refractory beta-blocker-associated anaphylaxis 1

ACE inhibitors and venom immunotherapy:

• ACE inhibitors associated with greater risk for severe reactions from venom immunotherapy and field stings 1
• Consider ACE inhibitor discontinuation for patients receiving venom immunotherapy 1
• Angiotensin receptor blockers (ARBs) have no evidence of increased anaphylaxis risk and are safer alternatives 1

Blood Pressure Monitoring Considerations

Potential bidirectional relationship:

• Some evidence suggests untreated allergic rhinitis may modestly elevate systolic blood pressure (approximately 3.5 mm Hg) 3
• Treatment of allergic rhinitis with intranasal corticosteroids and antihistamines may reduce systolic blood pressure by 7.4 mm Hg in hypertensive patients 4
• However, other studies show no significant blood pressure differences between allergic rhinitis patients and controls 5
• Routine blood pressure follow-up specifically for allergic rhinitis is not necessary 5

Common Pitfalls to Avoid

• Avoid phenylpropanolamine and ephedrine in hypertensive patients, as these raise blood pressure in a significant proportion of users 2, 6
• Do not use first-generation antihistamines as first-line therapy due to sedation, performance impairment, and anticholinergic effects 1
• Never withhold epinephrine for anaphylaxis in hypertensive patients, as there are no absolute contraindications 1
• Monitor NSAIDs carefully, as ibuprofen may elevate blood pressure if taken in maximum over-the-counter doses for more than a few days 2, 6